Pneumonia as a clinical form of meningococcal infection caused by serogroup W meningococcus


DOI: https://dx.doi.org/10.18565/epidem.2020.10.1.55-9

Vengerov Yu.Ya., Nagibina M.V., Ryzhov G.E., Krasnova S.V., Tsvetkova N.А., Smirnova T.Yu., Svistunova T.S., Matosovа S.V., Kulagina M.G., Kovalenko T.M.

1) A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia; 2) Infectious Diseases Clinical Hospital Two, Moscow Healthcare Department, Moscow, Russia; 3) Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Moscow, Russia
Objective. To analyze the clinical and pathogenetic features of generalized meningococcal infection (GMI) caused by N. meningitidis serogroup W.
Subjects and methods. The clinical presentation of the disease was studied using the case histories of 92 patients (90 adults and 2 children, whose age was 3 to 62 years) with GMI caused by N. meningitidis serogroup W, who were hospitalized in Moscow Infectious Diseases Clinical Hospital Two in 2011–2018. Clinical examples are given. The findings were statistically processed using the generally accepted parametric methods for variation statistics.
Results. The data of Moscow Infectious Diseases Clinical Hospital Two show that there has been an increase in the incidence of GMI caused by N. meningitidis serogroup W in the past 8 years from 1% in 2011 to 34.1% in 2018. Moreover, pneumonia is frequently diagnosed as an independent disease entity. Its development and generalized infection are often preceded by catarrhal laryngitis. In GMI caused by serogroup W meningococcus, pneumonia develops until a rash and meningeal syndrome appear. The disease is characterized by a severe course and high mortality rates and requires a longer inpatient treatment than infection caused by N. meningitidis serogroups A, B, and C.
Keywords: latex agglutination reactions, serogroup W meningococcus, generalized meningococcal infection, PCR, meningitis, meningococcemia, laryngitis, pneumonia
Read entire article

Literature


  1. Королева М.А., Миронов К.О., Королева И.С. Эпидемиологические особенности генерализованной формы менингококковой инфекции, обусловленной Neisseria meningitides серогруппы W, в мире и в Российской Федерации. Эпидемиол. инфекц. болезни. Актуал. вопр. 2018; (3): 16–23.

    Koroleva M. A., Mironov K.O., Koroleva I. S. [Epidemiological features of generalized meningococcal infection caused by Neisseria meningitidis serogroup W in the world and in the Russian Federation]. Èpidemiologii infekcionnye bolezni. Аktual'nye voprosy 2018; (3): 16–23. (In Russ.).



  2. Mustapha M.M., Marsh J.W., Harrison L.H. Global epidemiology of capsular group W meningococcal disease (1970–2015): Multifocal emergence and persistence of hypervirulent sequence type (ST)-11 clonal complex. Vaccine 2016; 34 (13): 1515–23.

  3. Нагибина М.В., Венгеров Ю.Я., Матосова С.В. Генерализованная форма менингококковой инфекции, вызванная N. meningitides серогруппы W, на территории г. Москвы в 2011–2016 гг. Инфекционные болезни: новости, мнения, обучение 2018; (6): 100–4.

    Nagibina M.V., Vengerov Yu.Ya., Matosova S.V. [Generalized form of meningococcal infection caused by N. meningitidis of serogroup W, on the territory of Moscow in 2011–2016]. Infectionnye bolezni: novosti, mneniya, obucheniye 2018; (7): 100–4. (In Russ.).



  4. Лобзин Ю.В., Иванова М.В., Скрипченко Н.В., Вильниц А.А., Карев В.Е.., Горелик Е.Ю., Середняков К.В., Конев А.И. Современные клинико-эпиде­мио­ло­гические особенности течения генерализованной менингококковой инфекции и новые возможности терапии. Инфекционные болезни: новости, мнения, обучение 2018; 7(1): 69–77.

    Lobzin Yu.V., Ivanova M.V., Skripchenko N.V., Vilnits A.A., Karev V.E., Gorelik E.Yu., Serednyakov K.V., Konev A.I. [Modern clinical and epidemiological features of generalized meningococcal infection and new possibilities of therapy]. Infectionnye bolezni: novosti, mneniya, obucheniye 2018; 7(1): 69–77. (In Russ).



  5. Veitch M.G., Owen R.L. Rise in invasive serogroup W meningococcal disease in Australia 2013–2015. Commun Dis Intell Q Rep. 2016; 40(4): E451–E453.

  6. Tsang R.S., Hoang L., Tyrrell G.J., Mininon J., Van Caeseele P., Kus J.V., Lefebvre B. Increase in ST-11 serogroup W Neisseria meningitidis invasive meningococcal disease in Canada, 2016–2018. Can. Commun Dis. Rep. 2019; 45(6): 164–9.

  7. Knol M., Ruijs W.L.M., Melker H.E., Berbers G.A.M., van der Ende A. Sudden increase of invasive meningococcal disease serogroup W in 2015 and 2016 [Plotselingetoename van invasievemeningokokkenziekteserogroep W in 2015 en 2016]. Infectieziekten Bulletin 2017; 28(1): 23–8.


About the Autors

Yury Ya. Vengerov, MD; Professor, Department of Infectious Diseases and Epidemiology, A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia; е-mail: tropbol@mail.ru; ORCID: https://orcid.org/0000-0001-8939-1690
Margarita V. Nagibina, MD, Associate Professor, Department of Infectious Diseases and Epidemiology, A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia; е-mail: infektor03@gmail.com; ORCID: https://orcid.org/0000-0001-5327-9824
Gleb E. Ryzhov, Laboratory Assistant, Department of Infectious Diseases and Epidemiology, A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia; е-mail: ryzhov151@gmail.com; ORCID: https://orcid.org/0000-0002-6638-7602
Svetlana V. Krasnova, Cand. Med. Sci., Chief Physician, Infectious Diseases Clinical Hospital Two, Moscow Healthcare Department, Moscow, Russia; е-mail: ikb2.ru
Natalia A. Tsvetkova, Deputy Chief Physician, Infectious Diseases Clinical Hospital Two, Moscow Healthcare Department, Moscow, Russia; е-mail: ikb2.ru
Tatiana Yu. Smirnova, Head, Infectious Diseases Department Three, Infectious Diseases Clinical Hospital Two, Moscow Healthcare Department, Moscow, Russia; е-mail: ikb2.ru; ORCID: https://orcid.org/0000-0002-5846-8568
Tatiana S. Svistunova, Cand. Med. Sci., Head, Bacteriology Laboratory, Infectious Diseases Clinical Hospital Two, Moscow Healthcare Department, Moscow, Russia; е-mail: ikb2.ru; ORCID: https: //orcid. org/ 0000-0001-7928-7451
Svetlana V. Matosova, Junior Researcher, Department of Molecular Diagnosis and Epidemiology, Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Moscow, Russia; е-mail: svetlana.matosova@cmd.su;ORCID: https://orcid.org/0000-0002-0460-6056
Margarita G. Kulagina, Cand. Med. Sci., Associate Professor, Department of Infectious Diseases and Epidemiology, A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia; е-mail: kulaginamg@mail.ru;
Tatiana M. Kovalenko, Head, Express Laboratory, Infectious Diseases Clinical Hospital Two, Moscow, Russia; е-mail: ikb2.ru


Similar Articles

Back to Content

Бионика Медиа